Vincent Digiovanni
Neurology · Wilkes Barre, PANPI 1497789135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novartis at 27.2% of the total. Reporting peaked in 2019 at $3,137 and has fallen 98.6% since, to $44 in 2025.
Across 211 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Biogen$566
- Teva Pharmaceuticals USA, Inc.$395
- Sunovion Pharmaceuticals Inc.$329
- Supernus Pharmaceuticals, Inc.$224
- AstraZeneca$200
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,855100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 51 | $1,050 |
| Biogen | 23 | $566 |
| Teva Pharmaceuticals USA, Inc. | 16 | $395 |
| Sunovion Pharmaceuticals Inc. | 37 | $329 |
| Supernus Pharmaceuticals, Inc. | 24 | $224 |
| AstraZeneca | 8 | $200 |
| Eisai Inc. | 6 | $196 |
| Amgen | 7 | $180 |
| Boston Scientific | 7 | $178 |
| Sanofi | 6 | $95 |
| Avanir Pharmaceuticals, Inc. | 6 | $92 |
| Lilly USA, LLC | 6 | $79 |
| Neurelis, Inc. | 1 | $77 |
| EMD Serono, Inc. | 3 | $37 |
| AbbVie | 2 | $34 |
| Genentech USA, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Livanova USA, Inc. | 1 | $13 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,855 in reported general payments places this provider in the 65th percentile of 941 neurology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Chloride0.9 % Sodium Chloride | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other neurology in Wilkes Barre
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Ravi DukkipatiYork$936K
- Brad KleinAbington$927K
- Stephanie Nahas-GeigerPhiladelphia$786K
- John KhouryAbington$686K
- Amit Bar-OrPhiladelphia$596K
- Behrang SaminejadAllentown$594K
- Anoopum GuptaPittsburgh$592K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.